Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
42.03 USD | -1.22% | -2.84% | -16.92% |
Mar. 13 | Sector Update: Health Care Stocks Gain Premarket Wednesday | MT |
Mar. 13 | Ionis Pharmaceuticals' Phase 2 Study of ION224 Achieves Liver Histologic Improvement; Shares Up | MT |
Financials (USD)
Sales 2024 * | 635M | Sales 2025 * | 764M | Capitalization | 6.13B |
---|---|---|---|---|---|
Net income 2024 * | -583M | Net income 2025 * | -523M | EV / Sales 2024 * | 9.29 x |
Net cash position 2024 * | 226M | Net Debt 2025 * | 170M | EV / Sales 2025 * | 8.24 x |
P/E ratio 2024 * |
-10.4
x | P/E ratio 2025 * |
-11.9
x | Employees | 927 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.69% |
Latest transcript on Ionis Pharmaceuticals, Inc.
1 day | -1.22% | ||
1 week | -2.84% | ||
Current month | -7.03% | ||
1 month | -5.40% | ||
3 months | -17.12% | ||
6 months | -2.10% | ||
Current year | -16.92% |
Managers | Title | Age | Since |
---|---|---|---|
D. Walke
FOU | Founder | 58 | 12-06-30 |
Brett Monia
FOU | Founder | 62 | 89-01-09 |
Elizabeth Hougen
DFI | Director of Finance/CFO | 62 | 00-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Joseph Loscalzo
CHM | Chairman | 72 | 14-02-02 |
Brett Monia
FOU | Founder | 62 | 89-01-09 |
Joan Herman
BRD | Director/Board Member | 70 | 19-06-09 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
6.89% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-18 | 42.03 | -1.22% | 968,336 |
24-03-15 | 42.55 | +0.88% | 1,251,368 |
24-03-14 | 42.18 | -2.27% | 1,324,844 |
24-03-13 | 43.16 | -0.02% | 1,110,600 |
24-03-12 | 43.17 | -0.21% | 798,887 |
Delayed Quote Nasdaq, March 18, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.92% | 6.2B | |
+9.72% | 46B | |
+35.14% | 39.85B | |
+4.84% | 39.76B | |
-9.43% | 28.16B | |
+17.47% | 27.62B | |
-22.99% | 18.8B | |
+10.88% | 13.3B | |
+27.53% | 12.2B | |
-6.84% | 11.4B |